Skip to main content
SpringerLink
Log in

Opiate Modulation of Striatal Dopamine and Hippocampal Norepinephrine Release Following Morphine Withdrawal

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

When opiates are abruptly withdrawn after chronic treatment, increases in hippocampal noradre-nergic function are observed which are accompanied by decreases in striatal dopamine release. The latter effects have to shown to persist for several weeks following the onset of opiate withdrawal. We examined the long-term effects of opiate withdrawal on 4-aminopyridine and potassium stimulated release of striatal dopamine and hippocampal norepinephrine. Tissue samples were obtained either from rats that had been exposed to opiate withdrawal following a seven day morphine infusion or sham treated control subjects. At 48 hours after the onset of withdrawal (cessation of morphine infusions), slices were loaded with [3H] neurotransmitter, washed extensively, and exposed to different drug treatments. 4-aminopyridine induced concentration related increases in striatal dopamine release, which was 36% calcium independent. Similar values for fractional release of striatal dopamine were obtained in morphine withdrawn and control subjects, for both potassium and 4-aminopyridine induced release. In addition, thresholds for 4-aminopyridine or potassium induced release of striatal dopamine did not differ between control and morphine withdrawn subjects. Treatment with 1.0 μM morphine sulfate potentiated potassium evoked release of norepinephrine to an equal extent in both morphine withdrawn and sham treated hippocampal tissue. Exposure to a threshold concentration of potassium (8.0 mM), stimulated increased release of hippocampal norepinephrine in a significantly greater fraction of tissue samples obtained from morphine withdrawn animals. Although these results do not support changes in striatal dopamine release following opiate withdrawal, opiate mechanisms appear to be important determinants of in vitro hippocampal norepinephrine release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Di Chiara G., and Imperato A. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc. Natl. Acad. Sci. USA 85:5274–5278.

    Google Scholar 

  2. Acquas E., Carboni E., and Di Chiara G. 1991. Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur. J. Pharm. 193:133–134.

    Google Scholar 

  3. Acquas E., and Di Chiara G. 1992. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J. Neurochem. 58:1620–1625.

    PubMed  Google Scholar 

  4. Spanagel R., Almeida O. F., and Shippenberg T. S. 1993. Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse 14:243–245.

    PubMed  Google Scholar 

  5. Spangel R., Almeida O. F., Bartl C. and Shippenberg T. S. 1994. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology 115:121–127.

    PubMed  Google Scholar 

  6. Diana M., Pistis M., Muntoni A. and Gessa G. 1995. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharmacol. Exper. Ther. 272:781–785.

    Google Scholar 

  7. Rossetti Z. L., Melis F., Carboni S. and Gessa G. L. 1992. Dramatic depletion of mesolimbic extracellular dopamine after withdrawal from morphine, alcohol or cocaine: a common neurochemical substrate for drug dependence. Ann. N. Y. Acad. Sci. 654:513–516.

    PubMed  Google Scholar 

  8. Crippens D., and Robinson T. E. 1994. Withdrawal from morphine or amphetamine: different effects on dopamine in the ventral-medial striatum studied with microdialysis. Brain Res. 650:56–62.

    PubMed  Google Scholar 

  9. Tien Ril H. K. G. T., De Vries T. J., Wardeh G., Hogenboom F., Mulder A. H., and Schoffelmeer A. N. M. 1993. Long-lasting reciprocal changes in striatal dopamine and acetylcholine release upon morphine withdrawal. Europ. J. Pharm. 235:321–322.

    Google Scholar 

  10. Tjon G. H. K., De Vries T. J., Ronken E., Hogenboom F., Wardeh G., Mulder A. H., and Schoffelmeer A. N. M. 1994. Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta and kappa opioid receptor regulation. Europ. J. Pharm. 252:205–212.

    Google Scholar 

  11. Gudehithlu K. P., Tejwani G. A., and Bhargava H. N. 1991. Beta-endorphin and methionine-enkaphalin levels in discrete brain regions, spinal cord, pituitary gland, and plasma of morphine tolerant-dependent and abstinent rats. Brain Res. 553:284–288.

    PubMed  Google Scholar 

  12. Corrigall W. A., and Linseman M. A. 1988. Conditioned place preference produced by intra-hippocampal morphine. Pharmacol. Biochem. Behav. 30:787–792.

    PubMed  Google Scholar 

  13. Silverstone P. H., Done C., and Sharp T. 1993. In vivo monoamine release during naloxone precipitated withdrawal. Neuroreport 4:1043–1045.

    PubMed  Google Scholar 

  14. Done C., Silverstone P., and Sharp T. 1992. Effect of naloxone precipitated morphine withdrawal on noradrenaline release in rat hippocampus in vivo. Eur. J. Pharm. 215:333–336.

    Google Scholar 

  15. Silverstone P. H., Done C., and Sharp T. 1992. Clonidine but not nifedipine prevents the release of noradrenaline during naloxone precipitated opiate withdrawal; an in vivo microdialysis study in the rat. Psychopharmacology 109:235–238.

    PubMed  Google Scholar 

  16. Langer S. Z., and Cavero I. 1980. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents. Hyperten. 2:372–382.

    Google Scholar 

  17. Rasmussen K., Beitner-Johnson D. B., Krystal J. H., Aghajanian G. K., and Nestler E. J. 1990. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical mechanisms. J. Neurochem. 10:2308–2317.

    Google Scholar 

  18. Rasmussen K., and Aghajanian G. K. 1989. Withdrawal-induced activation of locus coeruleus neurons in opiate dependent rats: attenuation by lesions of the nucleus paragigantocellularis. Brain Res. 505:346–350.

    PubMed  Google Scholar 

  19. Laverty R., and Roth R. H. 1980. Clonidine reverses the increased norepinephrine turnover during morphine withdrawal in rats. Brain Res. 182:482–485.

    PubMed  Google Scholar 

  20. Crawley J. N., Laverty R., and Roth R. H. 1979. Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal. Europ. J. Pharm. 57:247–250.

    Google Scholar 

  21. Taylor J. R., Elsworth J. D., Garcia E. J., Grant S. J., Roth R. H., and Redmond D. E. 1988. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology 96:121–131.

    PubMed  Google Scholar 

  22. Maldonado R., and Koob G. F. 1993. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res. 605:128–138.

    PubMed  Google Scholar 

  23. Heffner T. G., Hartman J. A., and Seiden L. S. 1980. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13:453–456.

    PubMed  Google Scholar 

  24. Woodward J. J., and Harms J. 1992. Potentiation of N-Methyl-D-Aspartate stimulated dopamine release from rat brain slices by aluminum fluoride. J. Neurochem. 58:1547–1554.

    PubMed  Google Scholar 

  25. Dismukes K., and Mulder A. H. 1977. Effects of neuroleptics on release of tritiated dopamine from slices of rat corpus striatum. Naunyn-Schmied. Arch. Pharm. 297:23–29.

    Google Scholar 

  26. Arbilla S., and Langer S. Z. 1978. Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum. Nature 271:559–561.

    PubMed  Google Scholar 

  27. Fujinaga M., and Mazze R. I. 1988. Teratogenic and postnatal developmental studies of morphine in Sprague-Dawley rats. Teratology 38:401–410.

    PubMed  Google Scholar 

  28. Paronis C. A., and Holtzman S. G. 1992. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fetanyl in rats. J. Pharmacol. Exper. Ther. 262:1–9.

    Google Scholar 

  29. Rogawski M. A., and Barker J. L. 1983. Effects of 4-aminopyridine on calcium action potentials and calcium current under voltage clamp in spinal neurons. Brain Res. 280:180–185.

    Article  PubMed  Google Scholar 

  30. Mulder A., Wardeh G., Hogenboom F., and Frankhuyzen A. L. 1984. Kappa and delta opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308:278–280.

    PubMed  Google Scholar 

  31. Lubetzki C., Chesselet M. F., and Glowinski J. 1982. Modulation of dopamine release in rat striatal slices by delta opiate agonists. J. Pharmacol. Exper. Ther. 222:435–440.

    Google Scholar 

  32. Werling L. L., Frattali A., Portoghese P. S., Takemori A. E., and Cox B. M. 1988. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J. Pharmacol. Exper. Ther. 246:282–286.

    Google Scholar 

  33. Starr M. S. 1978. Investigation of possible interactions between substance P and transmitter mechanisms in the substantia nigra and corpus straitum of the rat. J. Pharm. Pharmac. 30:359–363.

    Google Scholar 

  34. Moises H. C., Smith C. B., Spengler R. N. and Hollingsworth P. J. 1986. Presynaptic alpha 2 adrenoreceptor function in dependent rats before and after morphine withdrawal. NIDA Research Monograph 75:579–582.

    PubMed  Google Scholar 

  35. Goldberg M. R., and Robertson D. 1983. Yohimbine: a pharmacologic probe for study of the alpha-2 adrenoreceptor. Pharmacologic Reviews 35:143–180.

    Google Scholar 

  36. Werling L. L., Brown S. R., and Cox B. M. 1987. Opioid receptor regulation of the release of norepinephrine in the brain. Neuropharmacology 26:987–996.

    PubMed  Google Scholar 

  37. Wimpey T. L., Opheim K. E., and Chavkin C. 1989. Effects of chronic morphine administration on the mu and delta opioid responses in the CA1 region of the rat hippocampus. J. Pharmacol. Exper. Ther. 251:405–411.

    Google Scholar 

  38. Kusama T., Murakoshi Y., and Murakami H. 1991. Withdrawal like responses of rat hippocampal slices following brief exposure to morphine. Jap. J. Pharm. 56:213–216.

    PubMed  Google Scholar 

  39. Bradley P. B., Gayton R. J., and Lambert L. A. 1978. Electrophysiological effects of opiates and opioid peptides. Pages 215–229, in Hughes J. (ed.), Centrally Acting Peptides, University Park Press, Baltimore.

    Google Scholar 

  40. Corrigall W. A. 1983. Opiates and the hippocampus: a review of the functional and morphological evidence. Pharmacol. Biochem. Behav. 18:255–262.

    PubMed  Google Scholar 

  41. North R. A., and Williams J. T. 1983. Neurophysiology of opiates and opioid peptides. Pages 89–105, in Smith J. E. and Lane J. D. (eds.), The Neurobiology of the Reward Process, Elsevier, New York.

    Google Scholar 

  42. Zieglgänsberger W., French E. D., Siggins G. R., and Bloom F. E. 1979. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science 205:415–417.

    PubMed  Google Scholar 

  43. Swearengen E., and Chavkin C. 1989. Comparison of opioid and GABA receptor control of excitability and membrane conductance in hippocampal CA1 pyramidal cells in rat. Neuropharmacology 28:689–697.

    PubMed  Google Scholar 

  44. Shen K. F., and Crain S. M. 1989. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res. 491:227–242.

    PubMed  Google Scholar 

  45. Crain S. M., Shen K. F., and Chalazonitis A. 1988. Opioids excite rather than inhibit sensory neurons after chronic opioid exposure of spinal cord-ganglion cultures. Brain Res. 455:99–109.

    PubMed  Google Scholar 

  46. Xu H., Smolens I., and Gintzler A. R. 1989. Opioids can enhance and inhibit the electrically evoked release of methionine-enkephalin. Brain Res. 504:36–42.

    PubMed  Google Scholar 

  47. Dafters R., and Taggart P. 1992. Biotelemetric investigation of morphine's thermic and kinetic effects in rats. Psychopharmacology 106:195–201.

    PubMed  Google Scholar 

  48. Grasing K., and Szeto H. 1993. EEG changes with different levels of morphine self-administration. Neuropharmacology 32:543–552.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, 08903

    Kenneth Grasing, Daniel Bills, Suchandra Ghosh, Stephan D. Schlussman & Amrish H. Patel

  2. Department of Pharmacology/Toxicology Medical College of Virginia, MCV Station, Richmond, Virginia, 23298

    John J. Woodward

Authors
  1. Kenneth Grasing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Bills
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Suchandra Ghosh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stephan D. Schlussman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amrish H. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John J. Woodward
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grasing, K., Bills, D., Ghosh, S. et al. Opiate Modulation of Striatal Dopamine and Hippocampal Norepinephrine Release Following Morphine Withdrawal. Neurochem Res 22, 239–248 (1997). https://doi.org/10.1023/A:1022474318541

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022474318541

Search

Navigation